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ORIGINAL RESEARCH Open Access
Computer-aided diagnosis for (123I)FP-CIT
imaging: impact on clinical reporting
Jonathan Christopher Taylor1* , Charles Romanowski2, Eleanor Lorenz1, Christine Lo3, Oliver Bandmann4
and John Fenner5
Abstract
Background: For (123I)FP-CIT imaging, a number of algorithms have shown high performance in distinguishing
normal patient images from those with disease, but none have yet been tested as part of reporting workflows. This
study aims to evaluate the impact on reporters’ performance of a computer-aided diagnosis (CADx) tool developed
from established machine learning technology.
Three experienced (123I)FP-CIT reporters (two radiologists and one clinical scientist) were asked to visually score 155
reconstructed clinical and research images on a 5-point diagnostic confidence scale (read 1). Once completed, the
process was then repeated (read 2). Immediately after submitting each image score for a second time, the CADx
system output was displayed to reporters alongside the image data. With this information available, the reporters
submitted a score for the third time (read 3). Comparisons between reads 1 and 2 provided evidence of intra-
operator reliability, and differences between reads 2 and 3 showed the impact of the CADx.
Results: The performance of all reporters demonstrated a degree of variability when analysing images through
visual analysis alone. However, inclusion of CADx improved consistency between reporters, for both clinical and
research data. The introduction of CADx increased the accuracy of the radiologists when reporting (unfamiliar)
research images but had less impact on the clinical scientist and caused no significant change in accuracy for the
clinical data.
Conclusions: The outcomes for this study indicate the value of CADx as a diagnostic aid in the clinic and
encourage future development for more refined incorporation into clinical practice.
Keywords: (123I)FP-CIT, Machine learning, Support vector machine, Computer-aided diagnosis
Background
(123I)FP-CIT (ioflupane) single-photon emission computed
tomography (SPECT) is routinely used for assessment and
differential diagnosis of patients with Parkinsonian syn-
dromes. (123I)FP-CIT SPECT is pathological in patients
with any neurodegenerative form of Parkinsonism,
including not only classical Parkinson’s disease (PD), but
also atypical Parkinsonian disorders such as multiple
system atrophy (MSA) or progressive supranuclear palsy
(PSP). It is normal in patients with non-neurodegenerative
movement disorders such as drug-induced Parkinsonism
or essential tremor. In recent years, different automated
classification algorithms have been developed which aim to
accurately separate these images into binary diagnostic
groups: either with disease or without disease. Many such
classifiers are based on machine learning approaches. For
instance, Palumbo et al. created classifiers based on
support vector machines (SVMs) and neural networks to
separate patients with PD from those without [1]. Huertas-
Fernández et al. developed and evaluated models based on
logistic regression, linear discriminant analysis and SVMs
to differentiate between patients with PD and vascular
Parkinsonism [2]. A summary of recently published ma-
chine learning algorithms for (123I)FP-CIT classification is
presented in recent work by Taylor [3]. Performance
figures from many of these classification tools appear to be
impressive, with accuracies in excess of 95% commonly
reported [3]. However, it is not yet clear whether such
algorithms provide benefits in the clinic in terms of
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increased diagnostic accuracy or consistency as compared
to standard reporting procedures.
The likely use for automated classifiers in (123I)FP-CIT
imaging, and for other areas of nuclear medicine in the
near term, is either as an independent assistant to the
radiologist or as a training/audit tool, whereby reporter
performance is compared to an independent assessment.
In this study, the first scenario is considered, where the
classifier performs the role of a second reporter, giving a
second opinion on image appearances, which may
influence the reporter’s final diagnostic decision. Using
classification algorithms in this way is often referred to
as computer-aided diagnosis (CADx).
In (123I)FP-CIT, assistive reporting software, in the form
of semi-quantification, is already established. Here, relative
uptake in striatal regions of interest is compared to an
area of non-specific uptake and displayed alongside refer-
ence values. This provides radiologists with a parameter
that can be related to the likelihood of disease being
present. Use of such tools has been shown to increase
consistency between reporters and improve confidence
[4–9]. However, semi-quantification is a limited diagnostic
tool. Firstly, standalone performance has been shown to
be inferior to that of even relatively simple machine
learning algorithms [3]. Furthermore, semi-
quantification software may provide large numbers of
uptake ratios, each with their own associated normal
range. It can be challenging to interpret each of these
sets of figures to give an overall opinion on image ap-
pearances. Machine learning tools, on the other hand,
can be tuned to provide just a single output related
to the probability of disease being present. Therefore,
there is potential for CADx systems based on ma-
chine learning algorithms to provide more effective
assistance to reporters, to give improved reporting
performance. To date, there has been no exploration
of the potential for automated classifiers in clinical,
computer-aided (123I)FP-CIT reporting. This limits the
usefulness of this approach.
The following study aims to address this issue by exam-
ining the performance of experienced reporters, with and
without assistance from an automated classifier. Although
the automated classifier is based on a particular machine
learning methodology, results are likely to be reflective of
the potential benefits of any highly performing binary
classification tool and therefore provide insights into the
general impact of CADx on (123I)FP-CIT reporting. Two
contrasting datasets are used in this study, one based on
historical clinical data from a single hospital and the
other based on research data acquired from a number
of other hospitals under a different acquisition protocol
(downloaded from the Parkinson’s Progression Markers
Initiative (PPMI) website, http://www.ppmi-info.org/).
By selecting two contrasting cohorts, findings provide
evidence of the impact of CADx beyond a single set of
specific acquisition conditions and patient characteristics.
Methods
Automated classifier
In this study, a simple machine learning methodology
was adopted for creation of classifiers, which has shown
high performance in previous tests. Briefly, the algorithm
consisted of a linear support vector machine (SVM) with
input features derived from the first five principal com-
ponents of image voxel intensities (ordered according to
reducing variance) and patient age. Spatial and intensity
normalisation was applied to images before training the
algorithm. Spatial normalisation was achieved through
multi-stage, automated, affine registration, and intensity
normalisation was achieved by dividing all voxel inten-
sities by the mean value in the occipital lobe (see [3],
algorithm ML 2 for more details). An appropriate value
for the ‘C’ hyperparameter in the SVM algorithm was se-
lected through initial repeated, 10-fold cross-validation.
Algorithm training was completed using Matlab software
(Matlab, Natick, USA) and the libSVM library [10].
Data
Three hundred fifty-nine historical (123I)FP-CIT datasets
were extracted from the archives at Sheffield Teaching
Hospitals NHS Foundation Trust, for patients scanned
between May 2007 and May 2015, after excluding
images where significant vascular disease was identified
in concomitant MRI brain scans, or where the images
contained significant artefacts. All patient images were
acquired from dual-headed gamma cameras, manufac-
tured by GE (3 GE Infinia and 1 GE Millenium, GE
Healthcare, Chicago, USA), and all reconstructions were
performed using the same GE Xeleris v2.1 software (GE
Healthcare, Chicago, USA) and settings (ordered subset
expectation maximisation with two iterations, 10 subsets
and no scatter or attenuation correction). See Table 1 for
a summary of the key patient preparation and image
acquisition parameters.
Table 1 Summary of the acquisition and patient preparation
parameters for the local and PPMI databases
Parameter Local database PPMI database
Administered activity 167–185 MBq 111–185 MBq
Injection-to-scan delay 3–6 h 3.5–4.5 h
Acquisition time 30 min 30–45 min
Acquisition pixel size 3.68 mm Variable (scanner dependent)
Number of projections 120 (over 360°) 90 or 120 (over 360°)
Energy window 159 keV ± 10% 159 keV± 10% and 122 keV± 10%
Collimator LEHR Variable (scanner dependent)
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The patient notes associated with the datasets, if avail-
able, were examined by two neurologists to establish a ref-
erence diagnosis. Of the examined notes, there were 55
patients for which a clinical diagnosis could be established
with high confidence, based on the Queen Square Brain
Bank criteria for the diagnosis of PD. Thirty-three of these
were classified as having pre-synaptic dopaminergic deficit
(PDD) and 22 as not having PDD. The mean time of
follow-up post SPECT imaging was 31 months, with a
minimum of 15 months and a maximum of 51 months.
There were 34 male and 21 female patients in this subset.
At the time of scanning, their mean age was 66 years
(range 29–80 years). These cases were used for evaluating
diagnostic performance in the reporting study only. The
remaining 304 cases, without a reference clinical diagno-
sis, were divided into broad categories according to the
original image report (113 patients without PDD and 191
with PDD; see [3] for more details) and used purely for al-
gorithm training (classifier 1). Thus, there was a difference
in the labelling methodology for different subsets of the
local data, with algorithm training relying on data with a
reference diagnosis based on visual assessment only, and
reporting performance measured with data that had refer-
ence diagnosis based on clinical follow-up.
In addition, all the baseline (123I)FP-CIT examinations
from the Parkinson’s Progression Markers Initiative (PPMI)
database were also downloaded, for which a reference
clinical diagnosis was available in all cases (209 healthy
controls (HC), 448 with Parkinson’s disease (PD)). This
data was used to train and evaluate a separate classifier
(classifier 2), to provide additional insight into the potential
impact of CADx. This classifier used the same model,
hyperparameter and training procedures as classifier 1,
but with the different training data can be considered a
distinct algorithm. Image acquisition, reconstruction
and processing parameters for the PPMI dataset are
described elsewhere [11, 12]. However, the key patient
preparation and acquisition parameters are summarised
in Table 1. In contrast to the local data, PPMI images were
reconstructed with HOSEM software (Hermes Medical,
Stockholm, Sweden) utilising an OSEM algorithm with
eight iterations and eight subsets and attenuation
correction based on Chang’s method [13]. No scatter
correction was performed.
The PPMI data were split into training and test sub-
sets in such a way as to skew the test data towards more
difficult cases. This was done due to the fact that pa-
tients were only included in the PD group if their
SPECT scans displayed abnormal appearances, as
assessed by the PPMI core lab team. PD patients for
whom the SPECT scan was normal or equivocal were
excluded from the database. This screened collection of
data was therefore likely to be associated with higher
visual reporting accuracy as compared to the local
clinical data. To counteract this bias, more challenging
cases were preferentially selected for the test set, using
striatal binding ratio results as a surrogate marker of the
likely difficulty in classifying the data.
The PPMI data was split in half, maintaining the same
HC to PD ratio in both subgroups. The first half (328
patients) was used to train the classifier (classifier 2). For
the second half of the data, semi-quantification figures
were examined to find the 40 healthy controls with the
lowest putamenal striatal binding ratios (SBRs) and the
60 PD cases with the highest SBRs. This collection of
100 images, skewed towards more equivocal data (ac-
cording to semi-quantification results), was used in the
clinical evaluation. The remaining data, which was
neither used for algorithm training nor for testing with
radiologists, was excluded.
Reporting software
Routine reporting in Sheffield involves visual evaluation
of four reconstructed slices (7.4 mm thick) from the
centre of the rigidly registered brain and of a summed
image created by combining these axial slices. This data
is observed using Jview (Link Medical, Bramshill, UK), a
clinical platform based on Java software. An additional
Java applet was written to augment the functionality of
Jview, to force each set of patient images in the study to
be viewed in a standard format. An additional pane was
inserted on the left hand side of the screen, which con-
tained buttons allowing the user to move to the next
case or to input their diagnostic confidence score. This
pane was also used to display the output from the CADx
tool (at an appropriate stage of the study) and patient
age (see Fig. 1).
The CADx output was in the form of a probability
value. libSVM’s inbuilt function for converting SVM
scores to probabilities was adopted for the chosen classi-
fication algorithms in this study, which utilises cross-
validation to fit the available data to a logistic function.
The probability of belonging to the abnormal class was
estimated for all the patients. Given that the classifiers
were binary, for cases where P ≥ 0.5, the corresponding
probability of belonging to the normal class was 1-P (i.e.
less than 0.5). In these cases, the CADx output value
was displayed in red font. For patients where P < 0.5, the
corresponding probability of belonging to the normal
class was greater than 0.5 and a blue font was used in
the display.
Reporting methodology
The study involved three reporters examining test images,
presented in a random order, three times (an overview of
the study methodology is shown in Fig. 2). On the first
two occasions, reporters were asked to independently
score all images in the cohort according to their
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confidence in either a normal or abnormal classification,
through visual assessment alone. The second read com-
menced once all cases in the cohort had been scored once
and a subsequent delay time of at least 4 months had ex-
pired. The delay between reads 1 and 2 reduced the effects
from recall bias. In contrast, the second and third reads
were carried out together such that immediately after a re-
porter had recorded a score for a particular image, they
were then presented with the same image, but with the
probability value from the automated classifier displayed
prominently on the screen. Thus, comparison between the
first and (delayed) second visual reads provided an insight
into intra-reporter reliability. Comparison of the second
and third reads gave an indication of the impact of CADx
on reporting.
A 5-point diagnostic confidence scale was used through-
out, where a score of 1 was equivalent to having high con-
fidence that the image showed abnormal dopaminergic
function and a score of 5 was equivalent to having high
confidence that the image was normal. Scores of 2 and 4
were assigned to images where reporters were less
confident in their overall assessment but still favoured one
of the binary choices, and a score of 3 was used for any
equivocal cases.
This process was repeated for both the local and PPMI
datasets. Three reporters were recruited, two consultant
Fig. 2 Overview of study methodology. Repeated for both the local and PPMI data
Fig. 1 Display presented to reporters. Screenshot of the display presented to reporters during the study (in this case, the CADx output is visible)
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radiologists (Rad 1 and Rad 2) and one clinical scientist
(CS 1), all with greater than 5 years experience of read-
ing (123I)FP-CIT images as part of routine clinical duties
in a large teaching hospital. Each reporter used a clinical
workstation for viewing the images, in isolation from the
other reporters.
The metrics selected to evaluate reporter perform-
ance were sensitivity, specificity and diagnostic accur-
acy. These metrics were calculated by compressing the
submitted confidence scores into three classification
categories: with disease, without disease and equivocal.
In addition, inter- and intra-reporter reliability were
assessed using the intraclass correlation coefficient
(ICC), calculated from the raw diagnostic confidence
scores. ICC is a commonly applied metric for evaluat-
ing intra- and inter-rater reliability using ordinal or
interval rating scales. Values of ICC can range from 0
to 1 where 1 represents perfect reliability with no
measurement variability and 0 is representative of no
reliability. In this study, the two-way random model
was implemented for measuring inter-reporter reli-
ability, with single measures (i.e. ICC (2, 1)), and the
one-way random model with single measures (i.e.
ICC (1, 1)) implemented for assessing intra-reporter
reliability. These particular forms of ICC were se-
lected based on the guides provided by Rankin [14]
and Koo [15].
In addition to tests of reporter performance, the stan-
dalone accuracy, sensitivity and specificity of the CADx
tool was also measured for all the test cases. This was
done to confirm that the algorithm was sufficiently ac-
curate to be used as a reporting assistant and to quantify
the performance gap between the human reporters and
the software.
After the study had been completed, each reporter was
asked a series of set questions from a questionnaire in
separate interviews. This aspect of the study was primar-
ily designed to provide an insight into the CADx-
radiologist relationship, to assess the effects of the CADx
software on clinician decision-making; this is an import-
ant topic that has largely been ignored by researchers
[16]. The questions included a mix of open and closed
queries. Restricted response categories were included,
where possible, to allow for more straightforward
analysis.
Results
Figures 3, 4 and 5 summarise performance metrics for
each reporter for each of the three reads, for local data
and PPMI data respectively. Standalone performance of
the CADx tool is also shown. The time delay between
reads 1 and 2 ranged from 137 to 356 days across the two
datasets and three reporters, well in excess of 4 months.
Reporters’ confidence scores changed in approximately
13% of cases for the local data and in approximately 17%
of cases for the PPMI data after being exposed to the
CADx software output (i.e. comparing reads 2 and 3).
Intra- and inter-reporter reliability results are shown in
Table 2 and Fig. 6. Separate inter-reporter reliability
figures are displayed considering all three reporters to-
gether, then considering just the radiologists alone.
Table 3 summarises responses received to the main
questions in the questionnaire.
Discussion
This work considered the use of automated classifiers as
a computer-aided diagnosis tool for (123I)FP-CIT
imaging. Analysis of Figs. 3, 4 and 5 suggests that there
was relatively high variation in reporters’ performance
metrics between the first and second reads in some
cases, for both sets of data. For instance, the diagnostic
accuracy of CS1 changed from 0.82 to 0.91 when
Fig. 3 Diagnostic accuracy figures for the the image reads. Diagnostic accuracy figures for the three image reads, for local data (a) and PPMI data
(b). Standalone CADx performance is also shown, for comparison
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reporting the same set of local images. This suggests
that there is a reasonable degree of intra-reporter vari-
ability when analysing images visually, even for experi-
enced reporters. These findings were unexpected and
may be related to the fact that there was a relatively long
time gap between image reads, such that reporters’ im-
pressions of what constitutes a normal or abnormal
image may have drifted. Patient age was not displayed to
reporters during read 1 but was available during reads 2
and 3. This may also have introduced additional variabil-
ity. However, such variability may be an exaggeration of
what is normally expected in the local clinical service,
where a group reporting scenario is used routinely, with
semi-quantitative results available. This may help to
ameliorate the effects of individuals’ changing visual im-
pression. Nonetheless, results do provide a reminder
that human perception and understanding of medical
images is not a constant and invites speculation that it
could be improved through routine use of assistive
software.
The increased consistency offered by CADx tools is
demonstrated by inter-reporter reliability results. Figure 6a
demonstrates that for the two radiologists at least, there
was a noticeable increase in the intraclass correlation coef-
ficient between reads 2 and 3, showing that there was
reduced variability in submitted confidence scores. For the
PPMI data, the 95% confidence interval bounds indicate
that the increase in reliability was statistically significant.
These trends are reinforced by percentage agreement fig-
ures: for the PPMI data, the radiologists had completed
agreement in confidence scores in 77 and 74% of cases for
reads 1 and 2, rising to 87% agreement after introduction
of CADx. However, the upward trend in ICC figures is less
clear when the clinical scientist was included in the ana-
lysis (see Fig. 6b).
Given the increased consistency between reporters
during read 3, in terms of their confidence in a particu-
lar classification, it is likely that the introduction of a
CADx system would also have benefits in terms of re-
duced intra-reporter variability. However, estimation of
Fig. 4 Sensitivity figures for the three image reads. Sensitivity figures for the three image reads, for local data (a) and PPMI data (b). Standalone
CADx performance is also shown, for comparison
Fig. 5 Specificity figures for the three image reads. Specificity figures for the three image reads, for local data (a) and PPMI data (b). Standalone
CADx performance is also shown, for comparison
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such an effect would require that the reporting exercise,
with CADx assistance, be repeated.
Comparing reads 2 and 3 (i.e. directly before and after
the CADx was shown to the reporter), there is evidence
of some uplift in performance for the PPMI data, where
accuracy, sensitivity and specificity either stayed the
same or increased for all reporters. Conversely, for the
local data, there was no clear change in performance as
a result of the introduction of CADx. These contrasting
results for the two different datasets could be partly
related to the reliability of the reference diagnoses for
the two different datasets. Classifier 1 was trained with
(local) data where the reference classification was
derived from the original image report, created through
reporters’ visual analysis of the SPECT data (with patient
notes and other imaging available). Thus, the CADx tool
was trained to the diagnostic performance level of con-
ventional reporting methods. Conversely, classifier 2 was
trained with PPMI data where the diagnoses of the pa-
tients was better established and was not solely reliant
on the (123I)FP-CIT scan result. In this case, standalone
performance of the algorithm could have exceeded that
achievable through visual interpretation, increasing the
chances of CADx having a significant impact on
reporters’ decisions.
For the PPMI data, it is again interesting to note the
contrasting performance results between the clinical
scientist (CS1) and the two radiologists (Rad1 and
Rad2). Further analysis of the data suggests that CS1
only changed his confidence score in 7% of cases for the
PPMI data after viewing CADx results, as compared to
21 and 22% for Rad1 and Rad2 respectively. A similar
but less marked trend was seen in the local data, where
CS1 changed his score in 6% of cases as compared to 9
and 23% for Rad1 and Rad2 respectively. This is consist-
ent with the radiologists relying more heavily on the
CADx decision than the clinical scientist, particularly for
the unfamiliar PPMI data.
In this study, the PPMI test data was deliberately
skewed towards more difficult cases in order to maxi-
mise the opportunity for CADx to influence results. This
was necessary because of the strict patient group defini-
tions set out in the PPMI protocol. In particular, scans
without evidence of dopaminergic deficit (SWEDD),
where patients display features associated with PD but
have normal SPECT scan appearances, are classified
separately to HC and PD groups. SWEDD cases were
excluded from the current study, which would ordinarily
lead to an increase in test accuracy beyond that which
might be expected in clinic. For illustrative purposes, ap-
plying classifier 2 to the 76 SWEDD cases in the PPMI
database gives an abnormal classification in only 7 of 76
patients (the remaining 69 cases are classified as belong-
ing to the non-diseased group).
Table 2 Intra-reporter reliability (ICC) results for all reporters, with 95% confidence intervals (CI), for PPMI data and local data
Intra-reporter reliability
PPMI Local
Reporter ICC 95% CI (lower) 95% CI (upper) ICC 95% CI (lower) 95% CI (upper)
Rad1 0.87 0.82 0.91 0.89 0.82 0.93
Rad2 0.95 0.92 0.96 0.93 0.88 0.96
CS1 0.91 0.87 0.94 0.88 0.80 0.93
Fig. 6 Inter-reporter reliability (ICC) results for each of the three image reads. Inter-reporter reliability (ICC) results for each of the three image
reads for PPMI data and local data. Graph (a) is derived from radiologist data only (Rad1 and Rad2); graph (b) is from all reporters. Whiskers
represent 95% confidence intervals
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The effects of skewing the PPMI test database can be
demonstrated through analysis of standalone CADx and
semi-quantitative performance figures. In previous work
[3], it was shown that a classifier based on five principal
components and a linear SVM achieved a mean diagnostic
accuracy of 0.97 for randomly sampled data, the joint
highest performance of all the machine learning methods
considered. In the current study, accuracy was lower, i.e.
0.92 for the skewed PPMI data. Similarly, a semi-
quantitative method based on finding the optimum point
on an ROC curve of putamen uptake values (SQ 17 in [3])
, gave a mean accuracy value of 0.95 for randomly selected
PPMI test data [3]. This was found to be the best perform-
ance achieved of all the tested semi-quantitative ap-
proaches. However, in the current study, the performance
for the same method dropped to 0.74 for skewed PPMI
data. Thus, by manipulating the PPMI data, results dem-
onstrate that it was possible to reduce algorithm accuracy,
by implication making the data more difficult to interpret
by reporters.
It is difficult to directly compare findings of the
current study to those of studies evaluating the effects of
semi-quantification on radiologists’ performance, mainly
due to differences in data used and methodology. How-
ever, the broad findings of this work—that CADx can
improve accuracy if adopted by reporters with limited
experience of the data and that consistency in terms of
diagnostic confidence scores may also improve as a re-
sult—are similar to much of those of the previous work
related to semi-quantification [4–9].
These broad similarities are perhaps surprising given
that machine learning algorithms have previously been
shown to differentiate themselves from a wide range of
semi-quantitative methods in terms of standalone per-
formance, albeit by a small margin in most cases [3].
Thus, although the CADx system used here offers
advantages over conventional semi-quantification ap-
proaches, questions remain as to whether this translates
into improved clinical performance above and beyond
that offered by semi-quantification.
Evaluation of the radiologist-CAD relationship is rarely
carried out. In this study, the questionnaires provided to
participating radiologists give a useful insight into
CADx’s influence on decision-making and how it could
be improved. The responses suggested that the CADx
tool generally agreed well with the reporters’ classifica-
tion decisions, with only a very limited number of dis-
agreements. This reflects the quantitative analysis above.
The classifiers mostly had a small or moderate impact
on decision-making processes, which was as expected
for an application where normal and abnormal appear-
ances are often relatively easy to identify. The most com-
mon comment was that the CADx tool gave reporters
added confidence in their decision, in a similar way to
what might be expected from the presence of a human
second reader.
Interestingly, all three reporters felt that having access
to both CADx and semi-quantification was preferable to
having access to one or the other. This implies that the
functionality of each was felt to be positive and
Table 3 Summary of responses to the questionnaire (restricted response categories only)
Question Responses
A lot Moderately A little Not at all Unsure
In general, how well did your initial reporting
decisions correlate with the CADx output?
Rad1 – – – –
Rad2
CS1
Substantial impact Moderate impact Small impact No impact Unsure
In general, how would you rate the impact of the
CADx algorithm on your reporting decisions?
– Rad1 Rad2 – –
CS1
CADx Semi-quant Both Unsure
Would you prefer to have CADx for assistive DaTSCAN
reporting or semi-quantification? Or Both?
– – Rad1 –
Rad2
CS1
Yes (substantial benefit) Yes (moderate benefit) Yes (small benefit) No Unsure
Would it benefit you if the CADx system also provided
information on how it came to its decision (e.g. reduced
putamen uptake, high background uptake)
– CS1 Rad1 – –
Rad2
Substantial benefit Moderate benefit Small benefit No benefit Unsure
To what extent would the CADx system be a useful
training tool to improve DaTSCAN reporting performance
for inexperienced clinicians?
Rad2 Rad1 – – CS1
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complementary. It might be speculated that a greater
impact on reporting performance can be measured by
performing a clinical study using a combined software
algorithm that outputs both striatal binding ratios and
overall probabilities.
The questionnaire results provide additional evidence that
the approaches and opinions of the two radiologists were
close to each other but differed from that of the clinical sci-
entist. In general, the clinical scientist was less positive about
the CADx tool and more cautious about relying upon it.
The testing scenario was associated with some limita-
tions. As mentioned previously, patients’ clinical history
was not available to reporters as it would have been in
clinic. If such information were available, the impact of
CADx may have been different. However, machine learn-
ing algorithms can also make use of clinical history data,
and the addition of these inputs may help to rebalance
relative performance. Secondly, patient age was only pro-
vided to reporters on reads 2 and 3. This may have caused
additional intra-reporter variability. Even so, the data im-
plies that the impact of CADx for the radiologists was at
least as big as any differences in reporting performance
attributed to inclusion/exclusion of patient age.
The reference diagnoses of all the images studied was
binary (i.e. either with or without disease). However, the
5-point confidence scale used by reporters associated a
score of 3 with an equivocal classification, giving users a
choice of three different classifications. This mismatch
dictated that accuracy, sensitivity and specificity were all
negatively affected whenever a reporter submitted an
equivocal confidence score. Although a score of 3 was
selected in less than 3% of cases, this suggests that metrics
of diagnostic performance may be more pessimistic than
might have been the case if only two classifications were
available for users to select. The diagnostic confidence
scores reported are likely to be closely correlated with
disease severity. However, it should be emphasised that
these are distinct concepts. If a disease severity scale had
been provided to reporters, the intra- and inter-operator
variability results may have been slightly different.
In respect of wider application, this study examined
two classifiers (classifiers 1 and 2) trained separately with
data from distinct sources. There may be a negative im-
pact on classifier performance should the algorithms be
applied to data acquired from different equipment, in
different institutions. Indeed, the classifier calibrations
applied to convert classifier outputs into probabilities
may be misleading under these circumstances. If ma-
chine learning tools are to be used more widely, these is-
sues require further investigation.
Conclusions
This study represents a comparative diagnostic exercise
involving identification of patients with pre-synaptic
dopaminergic deficit for two sets of data (local, PPMI) using
established and CADx reporting methods. The perform-
ance of all the experienced reporters demonstrated a degree
of variability when analysing images through visual analysis
alone. However, inclusion of CADx improved accuracy,
sensitivity and specificity for two experienced radiologists,
when viewing (unfamiliar) PPMI data.
In addition, the introduction of CADx increased
consistency between the two radiologists, in terms of their
diagnostic confidence scores, for both the PPMI and local
data. Clinical scientist reporting performance was less
affected by the CADx tool with little change in reporting
performance between reads 2 and 3, for both sets of
patient images. The more cautious approach of the clinical
scientist was also evident in responses to the question-
naire, which sought to assess usability of the tool. These
qualitative results also revealed that all reporters would
prefer to have access to both semi-quantification and
CADx in clinic, rather than one or other in isolation. The
outcomes for this study indicate the value of CADx as a
diagnostic aid in the clinic and encourage future develop-
ment for more refined incorporation into clinical practice.
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